<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Anesthesia Management in Patient with Plasminogen Deficiency for Cesarean Section (C/S): A Case Report
2
Anesthesia Management in Rare Case: Cutis Laxa Syndrome
3
Anesthesia Management in Redo Mitral Valve Replacement Surgery in a Patient with a Rare Blood Group: A Case Report
4
ANESTHESIA MANAGEMENT OF A JEHOVAH’S WITNESS PATIENT WITH PHEOCHROMOCYTOMA UNDERGOING OFF PUMP CORONARY ARTERY BYPASS GRAFT SURGERY - A Case Report -
5
Anesthesia Management of a Patient with Lumbar Spinal Stenosis and Tracheal Stenting
6
Anesthesia Management of a Patient with Papillon-Lefevre Syndrome: A Case Report
7
Anesthesia Management of Electroconvulsive Therapy at the Late of Pregnancy: A Case Report
8
Anesthesia Management of Vitrectomy in a Patient with Sturge-Weber Syndrome
9
Anesthesia Methods in Pregnant Women: A Review Study
10
Anesthesia of juvenile Persian sturgeon, Acipenser persicus; Borodin 1897, by peppermint, Mentha piperita, extract – Anesthetic efficacy, stress response and behavior
11
ANESTHESIA OUTCOME PREDICTION
12
Anesthesia Preoperative Clinic Evaluation of Obstructive Sleep Apnea Using Nasal Fiberoptic Videoendoscopy: A Pilot Study Comparison with Polysomnography
13
Anesthesia Preoperative Clinic Referral for Elevated Hba1c Reduces Complication Rate in Diabetic Patients Undergoing Total Joint Arthroplasty
14
ANESTHESIA PROTOCOL FOR LIVER TRANSPLANT
15
Anesthesia Related Complications of Gastrointestinal Endoscopies; A Retrospective Descriptive Study
16
Anesthesia Teaching for Undergraduates; Bringing the Operating Theatre to the Simulation Lab: A Pilot Study
17
Anesthesia technique and serum cytokine concentrations in the elective cesarean section
18
Anesthesia Techniques in In-Office Aesthetic Surgery: A Narrative Review
19
Anesthesia Type and Short-Term Outcomes in Open Treatment of Hand Fractures
20
ANESTHESIA WITH ETOMIDATE AND REMIFENTANIL FOR CESAREAN SECTION IN A PATIENT WITH SEVERE PERIPARTUM CARDIOMYOPATHY- A Case Report -
21
Anesthesia with Propofol in Grass Carp, Ctenopharyngodon idella, and its Effects on Electrocardiogram, Blood Gases and pH
22
Anesthesia, complications, and clinical outcome for ruptured intracranial aneurysms: a retrospective comparison between endovascular coiling and neurosurgical clipping
23
Anesthesia, Neural Information Processing, and Conscious Awareness
24
Anesthesia: Part of the solution
25
Anesthesia: The “Other Side” of Consciousness
26
Anesthesia—A Descent or a Jump into the Depths?
27
Anesthesia-Related Complaint Cases at Kermanshah Medical Council Between 1993 and 2011
28
Anesthesia-related morbidity and mortality: where are we? A descriptive study
29
Anesthésie générale en radiothérapie pédiatrique
30
Anesthesiologic and Surgical Experiences of the Spanish Role 2 Enhanced in Herat, Afghanistan
31
Anesthesiological approach to a case with FAHR syndrome
32
Anesthesiologist’s Perspective on a Child with Acute Lymphoblastic Leukemia undergoing Neurosurgery: Case Report
33
Anesthesiologists Have an Important Role in Preclinical Nurse Anesthesia Education
34
Anesthesiology residents’ perception towards educational environment using ATEEM in a medical school in Thailand
35
Anesthesiomics: Could a New Name Be Coined for Anesthesia?
36
Anesthetic action: The importance of the spinal cord to immobility
37
Anesthetic and analgesic efficacy, hemodynamic changes, andsedation following addition of dexmedetomidine to lignocainein intravenous regional anesthesia for minor hand surgery
38
ANESTHETIC AND ICU MANAGEMENT OF PERIPARTUM CARDIOMYOPATHY
39
Anesthetic approach to Niemann–Pick Type C patient for dental treatment
40
Anesthetic approach to patient with Down syndrome and Hallervorden-Spatz disease who underwent tooth extraction
41
Anesthetic Approach to the Patient with Intraabdominal Pseudocyst After Ventriculoperitoneal Shunt Dysfunction Performed for Hydrocephalus
42
Anesthetic Aspect Of Malaria Disease: A Brief Review
43
ANESTHETIC CARE OF THE PATIENT FOR ROBOTIC SURGERY
44
ANESTHETIC CARE OF THE PATIENT WITH OBSTRUCTIVE SLEEP APNEA
45
ANESTHETIC CHALLENGES IN ORO-FACIAL CLEFT REPAIR IN ILE-IFE, Nigeria
46
Anesthetic Challenges in Pregnancy with Wilson’s Disease Associated with Massive Splenomegaly Complicated with Intramyometrial Carboprost: A Case Report
47
ANESTHETIC CONSIDERATION FOR GERIATRIC OUTPATIENT
48
Anesthetic Consideration of Niemann-Pick Disease Type C
49
Anesthetic Considerations and Management of a Patient with Unsuspected Carcinoid Crisis During Hepa tic Tumor Resection
50
Anesthetic Considerations for Angelman Syndrome: Case Series and Review of the Literature
51
Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review
52
ANESTHETIC CONSIDERATIONS FOR PEDIATRIC CHEST TRAUMA
53
ANESTHETIC CONSIDERATIONS FOR THE NEONATE WITH TRACHEOESOPHAGEAL FISTULA
54
Anesthetic Considerations for the Patient with Systemic Lupus Erythematosus
55
Anesthetic Considerations in a Case of Peumatocele Following Chest Trauma: A Case Report
56
Anesthetic Considerations in a Case With Massive Recurrent Clivus Chordoma
57
Anesthetic considerations in a patient with Psoriasis undergoing CABG surgery
58
Anesthetic considerations in a patient with Takayasu’s arteritisfor cesarean section
59
Anesthetic considerations in medium-chain acyl-CoA dehydrogenase deficiency
60
Anesthetic Considerations in Patients Undergoing Bariatric Surgery: A Review Article
61
ANESTHETIC CONSIDERATIONS IN PATIENTS WITH CARDIOMYOPATHIES- A Review -
62
Anesthetic considerations of Palmoplantar Keratoderma (PPK), a case report.
63
Anesthetic Considerations of Patient with Parry Romberg Syndrome
64
Anesthetic Considerations of Sporadic Inclusion Body Myositis in an Elderly Man With Orthopedic Trauma
65
Anesthetic Control of 40-Hz Brain Activity and Implicit Memory
66
Anesthetic Conversion of Preexisting Labor Epidural Analgesia for Emergency Cesarean Section and Efficacy of Levobupivacaine with or Without Magnesium Sulphate: A Prospective Randomized Study
67
ANESTHETIC DEATHS IN A DEVELOPING COUNTRY
68
Anesthetic dental needle breakage
69
Anesthetic effect of tricaine methanesulfonate, clove oil and electroanesthesia on lysozyme activity of Oncorhynchus mykiss
70
Anesthetic effects of adding intrathecal neostigmine or magnesium sulphate to bupivacaine in patients under lower extremities surgeries
71
Anesthetic Efficacy of Articaine and Ketamine for Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis: A Prospective Randomized Double-Blind Study
72
Anesthetic efficacy of articaine/epinephrine plus mannitol in comparison with articaine/epinephrine anesthesia for inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: A randomized controlled clinical trial
73
Anesthetic Efficacy of Inferior Alveolar Nerve Block: Conventional versus Akinosi Technique
74
Anesthetic efficacy of ketamine, ketaminetramadol and ketamineketorolac in chicks
75
Anesthetic Efficacy of Lidocaine/Ketorolac in Inferior Alveolar Nerve Block in Patients with Irreversible Pulpitis: A Randomized Clinical Trial
76
Anesthetic Experience of 1000 Cases During 10 Years in Renal Transplantation: A Retrospective Study
77
Anesthetic gas control with neuro-fuzzy system in anesthesia
78
ANESTHETIC IMPLICATIONS OF ACUTE METHYLENEDIOXYMETHAMPHETAMINE INTOXICATION IN A PATIENT WITH TRAUMATIC INTRACEREBRAL HEMORRHAGE - Case Report-
79
Anesthetic Management “Arnold Chiari Malformation” in the well-known Case of Cystic Fibrosis
80
Anesthetic management and perioperative complications in transcatheter aortic valve implantation: the Turkish experience
81
Anesthetic Management and Postoperative Care of a Patient with CADASIL (Cerebral Arteriopathy, Autosomal Dominant, with Subcortical Infarcts and leukoencephalopathy) for Cesarean Section
82
Anesthetic management for elective lower segment cesareansection in a patient with systemic lupus erythematosus andthrombocytopenia
83
Anesthetic Management for Lower Limb Fracture in Severe Aortic Valve Stenosis and Fat Embolism: A Case Report and Review of Literature
84
Anesthetic Management for Tracheo-Bronchial Reconstruction
85
Anesthetic Management in a Child With Citrullinemia: A Case Report
86
Anesthetic Management in a Child With Niemann-Pick Disease
87
ANESTHETIC MANAGEMENT IN A PATIENT WITH CORNELIA DE LANGE SYNDROME
88
Anesthetic Management in a Patient with Mixed Connective Tissue Disease: a Case Report
89
Anesthetic Management in a Patient With Surgical Excision of Spinal Cords Hydatid Cyst: A Case Report
90
Anesthetic Management in a Patient With Type A Aortic Dissection and Superior Vena Cava Syndrome
91
Anesthetic Management in Complex Arch Surgery: Debranching of Innominate and Left Common Carotid Arteries in Extensive Aortic Dissection without Cardiopulmonary Bypass
92
Anesthetic Management of 29 Week Pregnant Patient Undergoing Craniotomy for Pituitary Macroadenoma
93
Anesthetic Management of a Case of Duchenne Muscular Dystrophy in Congestive Heart Failure with Compartment Syndrome of the Upper Limb for Emergency Fasciotomy
94
Anesthetic management of a dog with severe subaortic stenosis and mitral valve disease complicated with atrial fibrillation undergoing ovariohysterectomy
95
Anesthetic management of a low birth weight infant with immature teratoma
96
ANESTHETIC MANAGEMENT OF A MORBIDLY OBESE PARTURIENT UNDERGOING CESAREAN SECTION
97
ANESTHETIC MANAGEMENT OF A NEWBORN WITH A CERVICAL MENINGOMYELOCELE
98
Anesthetic Management of a Parturient with Spinal Muscle Atrophy for Cesarean Section: A Case Report
99
Anesthetic Management of a Patient with Achondroplasia Undergoing Adenotonsillectomy: A Case Report
100
Anesthetic Management of a Patient with DRESS Syndrome for Renal Transplantation
101
ANESTHETIC MANAGEMENT OF A PATIENT WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY UNDERGOING MODIFIED RADICAL MASTECTOMY
102
Anesthetic Management of a Patient with Myasthenia Gravis
103
ANESTHETIC MANAGEMENT OF A PATIENT WITH MYOTONIC DYSTROPHY FOR LAPAROSCOPIC CHOLECYSTECTOMY - A Case Report -
104
Anesthetic management of a patient with Nager Syndrome
105
Anesthetic management of a patient with β -thalassemia and superimposed pneumonia
106
Anesthetic Management of a Pediatric Patient with Arginase Deficiency
107
Anesthetic management of a scleroderma patient undergoing tricuspid valve replacement under cardiopulmonary bypass
108
ANESTHETIC MANAGEMENT OF ACHONDROPLASTIC DWARF UNDERGOING CESAREAN SECTION
109
Anesthetic Management of Achondroplastic Dwarf with Difficult Airway for Cadaveric Renal Transplantation: A Case Report
110
Anesthetic Management of an Infant Presenting with an Intrapericardial Tumor: A Case Report
111
Anesthetic Management of an Infant with Bilateral Radial Dysplasia and Isolated Patent Ductus Arteriosus: A Case Report and Brief Review of Literature
112
Anesthetic management of carcinoma of thyroid involving trachea in a patient with hypertrophic obstructive cardiomyopathy
113
Anesthetic Management of Cervical Disc Herniation in a Patient with Churg-Strauss Syndrome: A Case Report
114
Anesthetic Management of Cervical Disc Herniation in a Patient with Churg-Strauss Syndrome: A Case Report
115
Anesthetic management of children with Moyamoya disease
116
ANESTHETIC MANAGEMENT OF CHILDREN WITH RUBINSTEIN-TAYBI SYNDROME
117
Anesthetic management of conjoined twins undergoing one-stage surgical separation: A single center experience
118
Anesthetic Management of COVID-19 Associated Mucormycosis: A Narrative Review
119
ANESTHETIC MANAGEMENT OF CRITICALLY ILL PREGNANT WOMEN
120
Anesthetic management of diaphragmatic hernia repair in a dog: a case report and literature review of anesthetic techniques
121
Anesthetic Management of Difficult Airway Due to Maxillofacial Trauma in a Pregnant Patient Requiring Submental Intubation: A Case Report
122
ANESTHETIC MANAGEMENT OF DILATED CARDIOMYOPATHY - A Case report -
123
Anesthetic Management of Hysterosalpingo-oophorectomy in a Case with Severe Idiopathic Dilated Cardiomyopathy
124
ANESTHETIC MANAGEMENT OF IATROGENIC ESOPHAGEAL PERFORATION - Case Report and Literature Review -
125
Anesthetic management of ischemic heart disease with ejectionfraction of 35% in a patient of fracture neck femur
126
Anesthetic Management of Jervell and Lange-Nielsen Syndrome With Long QT Undergoing Surgical Sympathectomy: A Pediatric Case Report
127
Anesthetic management of laparoscopic dual renal transplantation
128
Anesthetic Management of Patients With Anterior Mediastinal Masses Undergoing Chamberlain Procedure (Anterior Mediastinostomy)
129
Anesthetic management of patients with Klippel-Feil syndrome, a case series
130
ANESTHETIC MANAGEMENT OF PEDIATRIC CARDIAC PATIENTS UNDERGOING NON CARDIAC SURGERY
131
ANESTHETIC MANAGEMENT OF PHEOCHROMOCYTOMA
132
Anesthetic Management of Rapid Ventricular Response Atrial Fibrillation in an Elderly Woman Using Remifentanil; A Case Report
133
Anesthetic Management of Simultaneous Coronary Artery bypass Grafting with Cardiopulmonary bypass and Extended Thymectomy in a Patient with Myasthenia Gravis
134
Anesthetic Management of T12 Schwannoma in a Patient with Churg-Strauss Syndrome: A Case Report
135
Anesthetic Management of Total Traumatic Avulsion of Mandible
136
Anesthetic Management ofUrgent Cesarean Section withUndiagnosed Transposition ofGreat Arteries
137
Anesthetic Management Recommendations Using a Machine Learning Algorithm to Reduce the Risk of Acute Kidney Injury After Cardiac Surgeries
138
Anesthetic Management with Epidural Analgesia in a Case of Thalassemia Intermedia
139
Anesthetic methods for reduction of acute shoulder dislocations: A prospective randomized study comparing intraarticular lidocaine with intravenous analgesia and sedation
140
Anesthetic pentobarbital inhibits proliferation and migration of malignant glioma cells
141
Anesthetic Propofol-Induced Gene Expression Changes in Patients Undergoing Coronary Artery Bypass Graft Surgery Based on Dynamical Differential Coexpression Network Analysis
142
Anesthetic Technique in a Patient With Multiple Sclerosis Scheduled for Laparoscopic Nephrectomy for a Renal Tumor: A Case Report
143
Anesthetic Technique Influences Brain Temperature During Cardiopulmonary Bypass in Dogs
144
Anesthetic techniques for pediatric thoracoscopy
145
ANESTHETIST EXPERIENCE FOR CLEFT LIP AND CLEFT PALATE REPAIR: A REVIEW OF 172 SMILE TRAIN SPONSORED PATIENTS AT HAYAT ABAD MEDICAL COMPLEX, PESHAWAR
146
AnestimationmethodforbasematupliftbehaviorofnuclearpowerplantbuildingsOriginalResearchArticle
147
Anethole, a Medicinal Plant Compound, Decreases the Production of Pro-Inflammatory TNF-α and IL-1β in a Rat Model of LPS-Induced Periodontitis
148
Anethum graveolens and hyperlipidemia: A randomized clinical trial
149
Anethum graveolens L. Alleviates Sperm Damage by Limiting Oxidative Stress and Insulin Resistance in Diabetic Rats
150
Anethum Graveolens Linn (Umbelliferae) Extract Attenuates Stress-induced Urinary Biochemical Changes and Improves Cognition in Scopolamineinduced Amnesic Rats
151
Anethum graveolens seeds aqueous extract stimulates whole brain 5-hydroxytryptamine metabolism and reduces feeding behavior and body weight in obese rats
152
Anethum graveolens Supplementation Improves Insulin Sensitivity and Lipid Abnormality in Type 2 Diabetic Patients
153
Anethum graveolens, A new host of Meloidogyne incognita in Turkey
154
Aneugenic 2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one (DIMBOA) and 2,4-dihydroxy-1,4-benzoxazin-3-one (DIBOA) in sprouts of Triticum aestivum cultivars – A ‘safety health food’?
155
AN-EUL method for automatic interpretation of potential field data in unexploded ordnances (UXO) detection
156
Aneuploidies, deletion, and overexpression of TP53 gene in intestinal metaplasia of patients without gastric cancer
157
Aneuploidy Acts Both Oncogenically and as a Tumor Suppressor
158
Aneuploidy and Consistent Structural Chromosome Changes Associated with Transformation of Syrian Hamster Embryo Cells
159
Aneuploidy as a counter to “Mullerʹs ratchet” in cancer cells
160
Aneuploidy frequencies in semen fractions from ten oligoasthenoteratozoospermic patients donating sperm for intracytoplasmic sperm injection
161
Aneuploidy of chromosome 20 in invasive breast cancer correlates with poor outcome
162
Aneuploidy Precedes and Segregates with Chemical Carcinogenesis
163
Aneuploidy theory explains tumor formation, the absence of immune surveillance, and the failure of chemotherapy
164
Aneuploidy Underlies Rapid Adaptive Evolution of Yeast Cells Deprived of a Conserved Cytokinesis Motor
165
Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer’s disease
166
Aneurismal disease of different vascular territories: Is it a rare association?
167
Aneurysm after subclavian flap angioplasty repair of coarctation of the aorta
168
Aneurysm at the fenestrated anterior cerebral artery: Surgical anatomy and management
169
Aneurysm formation after patch aortoplasty repair (vossschulte): reoperation in adults with and without hypothermic circulatory arrest
170
Aneurysm of a Right-Sided Descending Aorta With a Normal Left-Sided Aortic Arch
171
Aneurysm of ascending and descending aorta in a 10-year-old-boy with Wiskott-Aldrich syndrome
172
Aneurysm of Brachial Artery Following Axillary Crutch
173
Aneurysm of circumflex coronary artery caused by cardiac vein and fistulous connection to the left ventricle identified on MDCT
174
Aneurysm of fossa ovalis in adults: A pathologic study
175
Aneurysm of saphenous vein bypass graft detected by first-pass radionuclide ventriculography, , ,
176
Aneurysm of saphenous vein graft causing anterior myocardial infarction by possibly compressing left internal mammary artery
177
Aneurysm of Sinus of Valsalva Dissecting Into Interventricular Septum
178
Aneurysm of sinus of Valsalva with extensive dissection of interventricular septum and left ventricular free wall
179
Aneurysm of the aortic root in the setting of Wiskott-Aldrich syndrome
180
Aneurysm of the iliac artery in an infant: Diagnosis by angiography with computed tomography (In French) : Arnould V, Worms A-M, Galloy M-A, Hoeffel J-C (J.C.H.: Service de Radiologie, Hôpital dʹEnfants de Vandoeuvre les Nancy, allée du Morvan, F-54511, V
181
Aneurysm of the Internal Carotid Artery Misdiagnosed as Cervical Paraganglioma; A Case Report and Literature Review
182
Aneurysm of the left atrial appendage
183
Aneurysm of the left pulmonary artery: surgical allograft repair
184
Aneurysm of the Left Sinus of Valsalva Producing Aortic Valve Regurgitation and Myocardial Ischemia
185
Aneurysm of the membranous interventricular septum demonstrated by multislice computed tomography
186
Aneurysm of the membranous ventricular septum resulting in pulmonary outflow tract obstruction in congenitally corrected transposition of the great arteries, ,
187
Aneurysm of the Mitral Valve: A Rare Complication of Aortic Valve Endocarditis
188
Aneurysm of the Pulmonary Artery in Fallot’s Tetralogy
189
Aneurysm of the right renal vein arising from an idiopathic arteriovenous fistula
190
Aneurysm shrinkage after endovascular repair of aortic diseases
191
Aneurysm Surgery: Step by Step to Meet the God
192
Aneurysmal Aorto-Left Ventricular Tunnel
193
Aneurysmal Bone Cyst after Femoral Derotational Osteotomy: A Case Report
194
Aneurysmal Bone Cyst in the First Rib
195
Aneurysmal Bone Cyst of Sphenoid Bone-A Case Report
196
Aneurysmal Bone Cyst of the Capitate: A rare case report
197
Aneurysmal bone cyst of the orbit: A case of rare location and review of the literature
198
Aneurysmal bone cyst originating from the first rib
199
Aneurysmal bone cyst with chromosomal changes involving 7q and 16p
200
Aneurysmal Bone Cyst: An Analysis of 38 Cases and Report of Four Unusual Surface Ones
201
Aneurysmal Bone Cyst: An Analysis of 38 Cases and Report of Four Unusual Surface Ones
202
Aneurysmal bone cyst-like areas as a sign of metastatic disease in the spinal column
203
Aneurysmal change in an internal mammary artery–pulmonary artery fistula
204
Aneurysmal Dilatation of the Contegra Bovine Jugular Vein Conduit After Reconstruction of the Right Ventricular Outflow Tract
205
Aneurysmal femoral neck cyst: Report of a paediatric case and review of literature
206
Aneurysmal pericardial patch producing right ventricular inflow obstruction
207
Aneurysmal rebleeding episode after lumbar puncture
208
Aneurysmal wall calcification predicts natural history of small abdominal aortic aneurysms
209
Aneurysmal walls in unruptured intracranial aneurysms
210
Aneurysmosis presenting as acute limb ischemia
211
Aneurysms After Coarctation Repair Associated With Hypoplastic Aortic Arch: Surgical Management Through Median Sternotomy
212
Aneurysms and Aortic Insufficiency: Two Very Rare Complications of Wilson’s Disease
213
Aneurysms complicating pulmonary autograft procedure for aortic valve replacement
214
Aneurysms of Sinus of Valsalva
215
Aneurysms of the portal venous system: Gray-scale and color doppler ultrasonographic findings with CT and mri correlation
216
Aneurysms of the Sinus of Valsalva in a Patient with Behcet's Disease
217
Aneurysms unsuitable for endovascular intervention: Surgical outcome and management challenges over a 5-year period following International Subarachnoid Haemorrhage Trial (ISAT)
218
Aneusomy detection by fluorescence in situ hybridization (FISH) using bladder washings: correlation with cytology, cytogenetics and clinical features predicts recurrence and defines test limitations
219
Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study
220
Aneutronics–thermalhydraulicsmodelforpreliminarystudiesonTRADEdynamicsOriginalResearchArticle
221
AnevaluationofreactorcoolingandcoupledhydrogenproductionprocessesusingthemodularheliumreactorOriginalResearchArticle
222
Anevaluationofriskmethodsforprioritizingfireprotectionfeatures:aprocedureforfirebarrierpenetrationsealsOriginalResearchArticle
223
ANew Algorithm to Impute the MissingValues in the Multivariate Case
224
ANew Low-Temperature Preparations of Some Simple and Mixed Co and Ni Dispersed Sulfides and Their Chemical Behavior in Reducing Atmosphere
225
ANew Scheme for Storage and Retrieval of Shared Text Files
226
Anewapproachtodesigningreducedscalethermal-hydraulicexperimentsOriginalResearchArticle
227
A-New-Closed-form-Mathematical-Approach-to-Achieve Minimum Phase Noise in Frequency Synthesizers
228
AnewfinitecloudmethodforcalculatingexternalexposuredoseinanuclearemergencyOriginalResearchArticle
229
AnewLMRsteamgeneratorfreefromSWRwithadoubletubebundleconfigurationOriginalResearchArticle
230
Anewphenomenologicalcriterionforpellet–claddinginteractionruptureOriginalResearchArticle
231
AnewversionofthereflectedcoreinhourequationanditssolutionOriginalResearchArticle
232
AnexperimentalandanalyticalstudyoftheeffectofaxialpowerprofileonCHFOriginalResearchArticle
233
AnexperimentalinvestigationonthecriticalheatfluxenhancementbymechanicalvibrationinverticalroundtubeOriginalResearchArticle
234
AnexperimentalstudyonquenchingofaradiallystratifiedheatedporousbedOriginalResearchArticle
235
Anexperimentalstudyonthecriticalheatfluxforlowflowofwaterinanon-uniformlyheatedverticalrodbundleoverawiderangeofpressureconditionsOriginalResearchArticle
236
AnexperimentalvalidationoftheguidelineforinelasticdesignanalysisthroughstructuralmodeltestsOriginalResearchArticle
237
AnF1-Module for the 3U4(3)-Amalgam Original Research Article
238
AnF1-Module for the 3U4(3)-Amalgam Original Research Article
239
Anfälle. Erfahrungen mit Epilepsie. Edited by Stefan Heiner, Margret Meyer-Brauns, and Lotte Habermann-Horstmeier
240
ANFIS and statistical based approach to prediction the peak pressure load of concrete pipes including glass fiber
241
ANFIS based Distillation Column Control
242
ANFIS Based Modeling of the Hormonal Effects of GLP-2 on the Mean Arterial Pressure and Blood Volume of Rats
243
ANFIS Controller for Non-holonomic Robots
244
ANFIS Controller for Non-holonomic Robots
245
ANFIS for high-pressure waterjet cleaning prediction
246
ANFIS modeling and validation of a variable speed wind turbine based on actual data
247
ANFIS Modeling to Forecast Maintenance Cost of Associative Information Technology Services
248
ANFIS Modelling of Carbon and Nitrogen Removal in Domestic Wastewater Treatment Plant
249
ANFIS modelling of the performance and emissions of a diesel engine using diesel fuel and biodiesel blends
250
ANFIS Speed Controller of IM Drives with Three-level DTC-based Neural Network
251
ANFIS-Based Diagnosis and Location of Stator Interturn Faults in PM Brushless DC Motors
252
ANFIS-based estimation of PV module equivalent parameters: application to astand-alone PV system with MPPT controller
253
ANG II activates P38 MAP kinase and ERK1/2, but not JNK, in vascular smooth muscle cells from SHR
254
Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways
255
Angel investors and the market for angel investments
256
Angel Rain (Tishtar): Case Study of Boghe of Gilan and Saghanefars of Mazandaran
257
Angel, handmaiden, battleaxe or whore? A study which examines changes in newly recruited student nurses’ attitudes to gender and nursing stereotypes
258
Angela Carter’s Heroes and Villains: A Dystopian Romance
259
Angelic machines: A philosophical dialogue (2)
260
Angelic semantics of fine-grained concurrency
261
Angelica archengelica extract induced perturbation of rat skin and tight junctional protein (ZO-1) of HaCaT cells
262
Angelica stimulates proliferation of murine bone marrow mononuclear cells by the MAPK pathway
263
Angelicae Gigantis Radix regulates mast cell-mediated allergic inflammation in vivo and in vitro
264
Angelman Syndrome: A Case Report
265
Angelman syndrome: a review of clinical and genetic aspects
266
Angelman Syndrome: Finding the Lost Arc
267
Angelman syndrome: is there a characteristic EEG?
268
Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation
269
Angelo Peccerillo, Plio-Quaternary volcanism in Italy: Petrology, geochemistry, geodynamics,
270
Angelonia flower mottle, a new disease of Angelonia angustifolia caused by a hitherto unknown carmovirus
271
Angels and spirits in the world of illness
272
Angels in the details: Comment on “The relationship between destination proximity, destination mix and physical activity behaviors”
273
Anger and aggression among drivers in three European countries
274
Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene
275
Anger and anger expression in relation to perceptions of social rank, entrapment and depressive symptoms
276
Anger and blood pressure readings in children
277
Anger and Gender Effects in Observed Supervisor-Subordinate Dyadic Interactions
278
Anger and hostility in adolescents: Relationships with self-reported attachment style and perceived parental rearing styles
279
Anger and hostility in maritally violent men: Conceptual distinctions, measurement issues, and literature review
280
Anger and hostility linked to coronary heart disease
281
Anger and impulsivity in non-clinical women
282
Anger and inhibitory control as moderators of childrenʹs hostile attributions and aggression
283
Anger and inhibitory control as moderators of childrenʹs hostile attributions and aggression
284
Anger and Irritability Symptoms among Youth with ODD: Cross-Informant Versus Source-Exclusive Syndromes
285
Anger and personality in eating disorders
286
Anger and psychopathology in prison inmates
287
Anger and somatization
288
Anger and the behavioral approach system
289
Anger as a cue to truthfulness
290
Anger as a Psychological Risk Factor of Hypertension
291
Anger assessment with the STAXI-CA: psychometric properties of a new instrument for children and adolescents
292
Anger at graphic evidence at Omagh inquest
293
Anger at US transplant waiting times “scare”
294
Anger Attacks in Major Depressive Disorder and Serum Levels of Homocysteine
295
Anger expression and essential hypertension: Behavioral response to confrontation
296
Anger expression in children and adolescents: A review of the empirical literature
297
Anger expression in Swiss adolescents: Establishing measurement invariance across gender in the AX scales
298
Anger expression, coping, and substance use in adolescent offenders
299
Anger expression, partner support, and quality of life in cancer patients
300
Anger in Adolescent Boy Athletes: a Comparison among Judo, Karate, Swimming and Non Athletes
301
Anger in chronic pain: Investigations of anger targets and intensity
302
Anger in healthy men: a PET study using script-driven imagery
303
Anger in prisoners: women are different from men
304
Anger in the Trajectory of Healing From Childhood Maltreatment
305
Anger in UK as discredited doctor is elected to doctorsʹ ruling body
306
Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids
307
Anger Management among Medical Undergraduate Students and Its Impact on Their Mental Health and Curricular Activities
308
Anger Management and Control in Social and Behavioral Sciences: A Systematic Review of Literature on Biopyschosocial Model
309
Anger Management and Factors that Influence Anger in Physicians
310
Anger Management May Save Your Life: New Insights Into Emotional Precipitants of Ventricular Arrhythmias
311
Anger management style and the prediction of treatment outcome among male and female chronic pain patients
312
Anger on ruling not to prosecute Irish doctors
313
Anger over dangerous withdrawal of antipsychotics from Pakistan
314
Anger over handling of Madagascarʹs cholera epidemic
315
Anger response styles and reaction to provocation
316
Anger rumination in Hong Kong and Great Britain: Validation of the scale and a cross-cultural comparison
317
Anger scale and anger types of patients with fifth metacarpal neck fracture
318
Anger scale and anger types of patients with fifth metacarpal neck fracture
319
Anger superiority effect for change detection and change blindness
320
Anger suppression mediates the relationship between optimism and natural killer cell cytotoxicity in men treated for localized prostate cancer
321
Anger symptoms and “delinquent” behavior in Tourette syndrome with and without attention deficit hyperactivity disorder
322
Anger types and the use of cigarettes and smokeless tobacco among Native American adolescents
323
Anger, aggression, and risky behavior: a comparison of high and low anger drivers
324
Anger, aggression, risky behavior, and crash-related outcomes in three groups of drivers
325
Anger, Anger Expression, and Suicidal Ideation in Korean Adolescents
326
Anger, Depression, and Anxiety in Cardiac Patients: The Complexity of Individual Differences in Psychological Risk
327
Anger, depression, and coping interactions in headache activity and adjustment: a controlled study
328
Anger, hostility, and male perpetrators of intimate partner violence: A meta-analytic review
329
Anger, negative emotions, and cardiovascular reactivity during interpersonal conflict in women
330
Anger, over-control and serious violent offending
331
Anger, psychopathology and cognitive inhibition: a study of UK servicemen
332
Anger, Suppressed Anger, and Risk of Adverse Events in Patients With Coronary Artery Disease
333
Anger-associated panic attacks in Cambodian refugees with PTSD; a multiple baseline examination of clinical data
334
Anger-in and hostility in myocardial infarction patients
335
Anger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators
336
Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines
337
Anggaran dan Ciri Fizikokimia Sisa Buangan Makanan di Bandar Baru Bangi
338
angian lattice boltzmann method for euler equati
339
Angina 1 year after percutaneous coronary intervention: A report from the NHLBI Dynamic Registry
340
Angina and origin of three major coronary arteries from independent ostia in right coronary sinus
341
Angina and sudden cardiac death caused by anomalous right coronary artery origin from above the left coronary cusp
342
Angina bullosa hemorrhagica: an idiopathic intraoral blistering disorder
343
Angina caused by coronary steal phenomenon
344
Angina caused by systolic compression of the left coronary artery as a result of pseudoaneurysm of the mitral-aortic intervalvular fibrosa
345
Angina for 14 years
346
Angina Pectoris and Atherosclerotic Risk Factors in the Multisite Cardiac Lifestyle Intervention Program
347
Angina pectoris and myocardial infarction with the use of leuprolife acetate
348
Angina pectoris caused by coronary microvascular spasm
349
Angina pectoris caused by microvascular spasm
350
Angina pectoris caused by microvascular spasm
351
Angina Pectoris or Myocardial Infarctions, Pulmonary Arteriovenous Malformations, Hereditary Hemorrhagic Telangiectasia, and Paradoxical Emboli
352
Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling Original Research Article
353
Angina pectoris: a headache
354
Angina reassessed: pain or protector?
355
Angina Self-Management Plan and Quality of Life, Anxiety and Depression in Post Coronary Angioplasty Patients
356
Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects
357
Angina-Induced Protection Against Myocardial Infarction in Adult and Elderly Patients: Loss of Preconditioning Mechanism in the Aging Heart?
358
Anginal Status and Prediction of Cardiac Events in Patients Enrolled in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
359
Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease
360
Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver
361
Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome
362
Angioarrestin mRNA expression in early-stage lung cancers
363
Angio-Associated Migratory Cell Protein and Smooth Muscle Cell Migration in Development of Restenosis and Atherosclerosis
364
Angioblasts in peripheral blood
365
Angiocardiographic findings in patients with biphasic T-wave inversion in precordial leads
366
Angiocardiography and magnetic resonance imaging to assess pulmonary regurgitation in repaired tetralogy of Fallot
367
Angiocentric Nasal T-Cell Lymphoma in a Patient with Idiopathic CD4+ Lymphocytopenia
368
Angiodysplasia: New Look at an Old Conundrum
369
Angiodysplastic lesions as a cause of colonic bleeding in patients with chronic renal disease: is there an association?
370
Angioedema and urticaria as early presentations of a COVID-19 patient: a case report
371
Angioedema Associated With Droperidol Administration, , ,
372
Angioedema Associated with Haloperidol
373
Angioedema associated with sumatriptan administration
374
Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation
375
Angioedema Due to Lamiaceae Allergy
376
Angioedema Due to Lamiaceae Allergy
377
Angioedema in a Patient with C1 Esterase Inhibitor Deficiency
378
Angioedema related to the ue of hyaluronidae in cataract urgery
379
Angioedema. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society (PTD) and Polish Society of Allergology (PTA)
380
Angioembolization as an effective alternative for hemostasis in intractable life-threatening maxillofacial trauma hemorrhage: case study
381
Angioembolization in itractable epistaxis — a tertiary care experience
382
Angioemboliziation of Internal Pudendal Artery for Treatment of Long Lasting Gross Hematuria After Transurethral Resection of the Prostate
383
Angiofibroma of the Nasal Septum
384
Angiofollicular lymph node hyperplasia (Castlemanʹs disease)
385
Angiogenèse et radiothérapie : tout ce qu’un oncologue radiothérapeute doit savoir
386
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma
387
Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
388
Angiogenesis and breast cancer
389
Angiogenesis and breast cancer metastasis
390
Angiogenesis and chronic disease
391
Angiogenesis and functional recovery demonstrated after minor stroke
392
Angiogenesis and growth factor expression in a model of transmyocardial revascularization
393
Angiogenesis and growth factor modulation induced by alternagin C, a snake venom disintegrin-like, cysteine-rich protein on a rat skin wound model
394
Angiogenesis and hepatocellular carcinoma
395
Angiogenesis and intrauterine growth restriction
396
Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches
397
Angiogenesis and Mast Cells Density in Oral and Esophageal Squamous Cell Carcinomas
398
Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia
399
Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancer
400
Angiogenesis and Morphometry of Bovine Placentas in Late Gestation from Embryos Produced In Vivo or In Vitro
401
Angiogenesis and musculogenesis as two facets of inflammatory post-ischemic tissue regeneration
402
Angiogenesis and Nitric Oxide in Elderly Men after Continuous and Interval Aerobic Training
403
Angiogenesis and placental growth in normal and compromised pregnancies
404
Angiogenesis and Tumor-Associated Macrophages in Different Grades of Oral Squamous Cell Carcinoma, Verrucous Carcinoma and Epithelial Dysplasia via Immunohistochemical Assessment of Expression of CD34 and CD68 Markers
405
Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum
406
Angiogenesis as targeted breast cancer therapy
407
Angiogenesis assays
408
ANGIOGENESIS EFFECTS OF CHINESE HERBAL SALVIA MILTIORRHIZA AFTER ACUTE MYOCARDIAL INFARCTION IN RATS
409
Angiogenesis factor in endometrial carcinoma: A new prognostic indicator?, ,
410
Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells
411
Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells
412
Angiogenesis in bone fracture healing: A bioregulatory model
413
Angiogenesis in cervical intraepithelial neoplasia and the risk of recurrence, ,
414
Angiogenesis in chronic myelogenous leukaemia
415
Angiogenesis in chronic myelogenous leukaemia
416
Angiogenesis in colon hyperplastic polyp
417
Angiogenesis in ductal breast carcinoma and its correlation with the prognostic parameters
418
Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis
419
Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation
420
Angiogenesis in ischemic human myocardium: clinical results after 3 years
421
Angiogenesis in Ischemic Stroke Patients Aged 30 - 80 years at Gatot Subroto Army Central Hospital (RSPAD) Jakarta
422
Angiogenesis in neovascularized free muscle grafts
423
Angiogenesis in odontogenic keratocyst and dentigerous cyst: Evaluation of JunB and VEGF expression
424
ANGIOGENESIS IN OPEN TIBIAL FRACTURES: A COMPARISON OF MUSCLE AND FASCIOCUTANEOUS FLAPS
425
Angiogenesis in ovarian cancer
426
Angiogenesis in ovarian follicular and luteal development
427
Angiogenesis in primary and metastatic epithelial ovarian carcinoma, ,
428
Angiogenesis in Rat Ischemic Hindlimb: Role of Human Bone Marrow-Derived Mesenchymal Stem Cells Transplantation
429
Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases
430
ANGIOGENESIS IN TISSUE ENGINEERING
431
Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures
432
Angiogenesis induced by autologous whole bone marrow stem cells seeded on collagen scaffolds in silicone nerve tubes. An experimental study
433
Angiogenesis induced by urothelial cells (HCV-29) and their v-ras and v-raf transfectants
434
Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: History and rationale
435
Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation
436
Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers Original Research Article
437
Angiogenesis inhibitors derived from thalidomide
438
Angiogenesis Is Enhanced in Ischemic Canine Myocardium by Transmyocardial Laser Revascularization
439
Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction
440
Angiogenesis modulatory activity of SC-CO2 leaf extract of guyabano (Annona muricata Linn.) using chick embryo chorioallantoic membrane assay
441
Angiogenesis of the ovary,
442
Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation
443
Angiogenesis with recombinant fibroblast growth factor-2 for claudication
444
Angiogenesis with recombinant fibroblast growth factor-2 for claudication
445
ANGIOGENESIS WITHIN ATHEROSCLEROTIC LESIONS BY STEM/PROGENITOR CELLS
446
Angiogenesis, Arteriogenesis, and Diabetes: Paradigm Reassessed?
447
Angiogenesis, myogenesis and cell therapy I
448
Angiogenesis, Myogenesis, and Cell Therapies
449
Angiogenesis, tumor necrosis factor-α and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease
450
Angiogenesis/myogenesis cell therapy
451
Angiogenesis/myogenesis/cell therapy II
452
Angiogenesis: A Critical Role in Locally Aggressive Behavior of Keratocystic Odontogenic Tumor
453
Angiogenic activitiy of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT)
454
Angiogenic activity in the sera of patients with post-kidney transplant erythrocytosis
455
Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice
456
Angiogenic Effect of Leptin in the Quail Chorioallantoic Membrane
457
Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro
458
Angiogenic effect of prostaglandin I 2 in relation with its effect on PPAR nuclear receptors
459
Angiogenic effect of the aqueous extract of Cynodon dactylon on human umbilical vein endothelial cells and granulation tissue in rat
460
ANGIOGENIC EFFECTS OF A NEW HMG-COA REDUCTASE INHIBITOR, PITAVASTATIN
461
Angiogenic Effects of Aerobic Training and Royal Jelly Consumption with Emphasis on the Role of miR-126 and miR-210 in the Aortic Artery of Ovariectomized Diabetic Rats
462
Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis
463
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells
464
Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease
465
Angiogenic growth factors in human dentine matrix
466
Angiogenic growth factors released in human dental pulp following orthodontic force
467
Angiogenic induction and cell migration in an orthopaedically expanded maxillary suture in the rat
468
Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma
469
Angiogenic response induced by acellular femoral matrix in vivo
470
Angiogenic responses are enhanced in mechanically and microscopically characterized, microbial transglutaminase crosslinked collagen matrices with increased stiffness
471
Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction
472
Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study
473
Angiogenin and osteopontin and coronary collateral circulation
474
Angiogenin plasma levels during pregnancy
475
Angiogenin: A marker for preterm delivery in midtrimester amniotic fluid, , , ,
476
Angiograph image restoration with the use of rule base fuzzy 2D Kalman filter
477
Angiographic 5-year follow-up study of right gastroepiploic artery grafts
478
Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)
479
Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting Stents
480
Angiographic Analysis of the Anatomic Relation of Coronary Arteries to Mitral and Tricuspid Annulus and Implications for Radiofrequency Ablation
481
Angiographic analysis of the angioplasty versus rotational atherectomy for the treatment of diffuse in-stent restenosis trial (ARTIST)
482
Angiographic anatomical variation of origin of left circumflex coronary artery in Basrah
483
Angiographic anatomy of the grafted left internal mammary artery
484
Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction tria
485
Angiographic and clinical characteristics associated with the development of q-wave and non-q–wave myocardial infarction in the thrombolysis in myocardial infarction (timi) 14 trial
486
Angiographic and clinical outcome following coronary stenting of small vessels : comparison with coronary stenting of large vessels
487
Angiographic and clinical outcome of mild to moderate nonocclusive unstented coronary artery dissection and the influence on coronary flow velocity reserve
488
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction
489
Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts
490
Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis
491
Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations
492
Angiographic and Interventional Radiological Management of Obscure Overt Gastrointestinal Bleeding
493
Angiographic and intravascular ultrasound predictors of in-stent restenosis
494
Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: Comparison with same drug-eluting overlapping stents
495
Angiographic and Magnetic Resonance Imaging Evaluation of In-Hospital Delay in Primary Percutaneous Intervention Delivery on Myocardial Salvage
496
Angiographic and morphologic features of the left ventricle in Ebsteinʹs malformation
497
Angiographic and procedural outcome after coronary angioplasty in high-risk subsets using a decremental diameter (tapered) balloon catheter
498
Angiographic and prognostic implications of an exaggerated exercise systolic blood pressure response and rest systolic blood pressure in adults undergoing evaluation for suspected coronary artery disease
499
Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries
500
Angiographic and volumetric intravascular ultrasound comparison between direct Sirolimus-Eluting stent implantation versus predilation
501
Angiographic aspects of ruptured plaque in patients with acute myocardial infarction: correlation with clinical and laboratory variables
502
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients
503
Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia
504
Angiographic changes in saphenous vein grafts are predictors of clinical outcomes
505
Angiographic changes in vein grafts: Stable surrogate or seductive siren?
506
Angiographic Characteristics of Coronary Disease and Postresuscitation Electrocardiograms in Patients With Aborted Cardiac Arrest Outside a Hospital
507
Angiographic characteristics of infarct-related and non-infarct-related stenoses in patients in whom stable angina progressed to acute myocardial infarction, ,
508
Angiographic complications in CADASIL
509
Angiographic complications of primary angioplasty
510
Angiographic coronary artery disease associated with hypertensive heart failure and normal ejection fraction. Insights from a prospective monocenter study
511
Angiographic correlates of “spotty” coronary artery calcium detected by electron-beam computed tomography in patients with normal or near-normal coronary angiograms
512
Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery
513
Angiographic Correlates of Graft Patency and Relationship to Clinical Outcomes
514
Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the bypass angioplasty revascularization investigation study (BARI)
515
Angiographic deterioration of target coronary artery narrowing as a result of percutaneous balloon angioplasty, ,
516
Angiographic embolization for arrest of bleeding after penetrating trauma to the abdomen
517
Angiographic Embolization of a Traumatic Pulmonary Pseudoaneurysm
518
Angiographic Evaluation of Myocardial Perfusion in Patients With Syndrome X
519
Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI
520
Angiographic evaluation of traumatic arterial injuries of the upper limbs: a retrospective study
521
Angiographic Evolution of Intracoronary Thrombus and Dissection Following Percutaneous Transluminal Coronary Angioplasty (The Thrombolysis and Angioplasty in Unstable Angina [TAUSA] Trial)
522
Angiographic Fate of Collateral Vessels After Surgical Revascularization of the Totally Occluded Left Anterior Descending Artery
523
Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome
524
Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angin and previous bypass surgery
525
Angiographic features, surgical management and outcomes of proximal middle cerebral artery aneurysms
526
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry
527
Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience
528
ANGIOGRAPHIC FINDINGS IN 130 PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE
529
Angiographic findings in Buerger disease
530
Angiographic findings in monozygotic twins with coronary artery disease
531
Angiographic findings in patients undergoing catheterization for recurrent symptoms within 30 days of successful coronary intervention
532
Angiographic findings in tumoral calcinosis
533
Angiographic Findings of Patients with Blunt or Penetrating Extremity Injuries: Focus on Indications and Contraindications
534
Angiographic Findings, Time Course of Regional and Global Left Ventricular Function, and Clinical Outcome in Diabetic Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Transluminal Coronary Angioplasty
535
Angiographic Follow-up of Internal Thoracic Artery for Free Bypass Grafting
536
Angiographic follow-up results of STent versus Atherectomy Randomized Trial (START)
537
Angiographic Lesion Severity and Subsequent Myocardial Infarction
538
Angiographic Localization of Potential Culprit Coronary Arteries in Patients With Interatrial Block Following a Positive Exercise Tolerance Test
539
Angiographic methods to assess human coronary angiogenesis
540
Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction
541
Angiographic Outcomes With Early Eptifibatide Therapy in Non–ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial)
542
Angiographic Patency of the Radial Artery Conduit in Coronary Artery Bypass Grafting
543
Angiographic Pattern of Restenosis Following Implantation of Overlapping Sirolimus-Eluting (Cypher) Stents
544
Angiographic Patterns of Drug-Eluting Stent Restenosis and One-Year Outcomes After Treatment With Repeated Percutaneous Coronary Intervention
545
Angiographic patterns of restenosis after paclitaxel-eluting stent implantation
546
Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction
547
Angiographic plaque complexity: the tip of the unstable plaque iceberg
548
Angiographic Predictors and Clinical Outcome of Acute Side Branch Occlusion after Coronary Artery Stent Implantation
549
Angiographic Predictors of 6-Month Patency of Bypass Grafts Implanted to the Right Coronary Artery: A Prospective Randomized Comparison of Gastroepiploic Artery and Saphenous Vein Grafts Original Research Article
550
Angiographic predictors of adverse outcomes in the modern interventional era
551
Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts
552
Angiographic predictors of neointimal thickening after successful coronary wall healing following percutaneous revascularization
553
Angiographic predictors of new coronary occlusions
554
Angiographic Predictors of Recurrent Stent Thrombosis (from the Outcome of PCI for Stent-ThrombosIs MultIcentre STudy [OPTIMIST])
555
Angiographic predictors of reocclusion after thrombolysis: Results from the thrombolysis in myocardial infarction (TIMI) 4 trial
556
Angiographic presence of myocardial bridge after successful percutaneous transluminal coronary angioplasty
557
Angiographic presentation of coronary artery spasm in heart transplant recipients
558
Angiographic profile in patients with congenital anomalous origin of the coronary arteries
559
Angiographic restenosis rate in patients with chronic total occlusions and subtotal stenoses after initially successful intracoronary stent placement
560
Angiographic results after the use of a sutureless aortic connector for proximal vein graft anastomoses
561
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)
562
Angiographic Results of the First Human Experience With the Biolimus A9 Drug-Eluting Stent for De Novo Coronary Lesions
563
Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia
564
Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus
565
Angiographic severity and extent of coronary artery disease in type 1 diabetes
566
Angiographic severity of coronary artery disease in patients with metabolic syndrome
567
Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis
568
Angiographic significance of a discordant ST-segment elevation of ≥5 millimeters in patients with ventricular-paced rhythm and acute myocardial infarction
569
Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: The Importance of Thrombus Burden Original Research Article
570
Angiographic study of aorta, coronary arteries, and left ventricular performance after neonatal arterial switch operation for simple transposition of the great arteries, ,
571
Angiographic study of Moyamoya disease and histological study in the external carotid artery system
572
Angiographic Surrogate End Points in Drug-Eluting Stent Trials: A Systematic Evaluation Based on Individual Patient Data From 11 Randomized, Controlled Trials Original Research Article
573
Angiographic variables predict increased riskfor adverse ischemic events after coronarystenting with glycoprotein IIb/IIIa inhibition: Results from the TARGET trial
574
Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation
575
Angiographic, intravascular ultrasound and functional findings early after orthotopic heart transplantation
576
Angiographic, ultrasonic, and angioscopic assessment of the coronary artery wall and lumen area configuration after directional atherectomy: The mechanism revisited
577
Angiographical and computed tomographic findings in diffuse pulmonary arteriovenous fistulas
578
Angiographical study of ramus intermedius coronary artery in Basrah
579
Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing
580
Angiographically evident atherosclerotic stenosis associated with myocardial bridging and risk factors for the artery stenosis located proximally to myocardial bridging
581
Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemi and familial combined hyperlipidemia: Correlation with high density lipoproteins
582
Angiographically silent left main disease detected by intravascular ultrasound: a marker for future adverse cardiac events
583
Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours
584
Angiography and interventional cardiology
585
Angiography and interventional cardiology Review Article
586
Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction
587
Angiography of potential cardiac donors
588
Angiography versus intravascular ultrasound assessment of coronary stent placement: observations from the AVID study
589
Angiography; an Inducer of TGF-Β during Early Atherosclerosis
590
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
591
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
592
Angioid streaks and other ocular complications of Pagetʹs disease of bone
593
Angioimmunoblastic lymphadenopathy-like T-cell lymphoma A case report and immunologic study
594
Angiokeratoma corporis diffusum without systemic features in a young Kashmiri female: a rare occurrence
595
Angioleiomyoma in the tonsil: an uncommon tumour in a rare site
596
Angioleiomyoma of the diaphragm
597
Angioleiomyoma of the Hand: A Case Series and Review of the Literature
598
Angioleiomyoma: a benign tumor with karyotypic aberrations
599
Angiolipoma of the breast with microcalcification: Mammographic, sonographic, and histologic appearances
600
Angiolymphoid hyperplasia with eosinophilia
601
Angiolymphoid hyperplasia with eosinophilia
602
ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA – A RARE ENTITY
603
Angioma serpiginosum successfully treated by a single session of intense pulsed light therapy
604
Angiomagnetic resonance imaging of iliofemorocaval venous thrombosis
605
Angiomatoid fibrous histiocytoma in mediastinum
606
Angiomatoid Fibrous Histiocytoma, A Great Mimicker – A Short Series of 3 Cases with EWSR1 Fusion
607
Angiomyofibroblastoma mimicking an inguinal hernia: a challenging diagnosis in a male patient
608
Angiomyofibroblastoma of the Vaginal Portion
609
Angiomyofibroblastoma of the Vulva
610
Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair
611
Angiomyolipoma and Malignant PEComa: Discussion of TwoRare Adrenal Tumors
612
Angiomyolipoma of the Adrenal Gland: A Case Report
613
Angiomyoma of the Hard Palate
614
Angiomyxolipoma; Report of a new case in subcutaneous tissue and review of the literature
615
Angiomyxoma Presenting as an Unusual Vaginal Mass
616
Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis
617
Angioneogenesis in rheumatoid arthritis
618
Angioneogenesis in rheumatoid arthritis
619
ANGIOPEPTIDES: NOVEL PEPTIDES THAT INDUCE ANGIOGENESIS
620
ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES
621
ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES
622
Angioplasty and stenting of the distal coronary anastomosis for graft failure immediately after coronary artery bypass grafting
623
Angioplasty for acute myocardial infarction in community hospital without surgical back-up: Response to Wharton and Angelini publications “should guidelines be changed?: Not whether but when”
624
Angioplasty for coarctation in different aged patients
625
Angioplasty for intermittent claudication
626
Angioplasty for lower-limb ischaemia: time for randomised controlled trials
627
Angioplasty for the late stent thrombosis, the new technical challenge: A single centre experience
628
Angioplasty Guidewire Velocity: A New Simple Method to Calculate Absolute Coronary Blood Velocity and Flow
629
Angioplasty in the stent era: results of a consecutive series of patients undergoing coronary angioplasty without surgical backup
630
Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA
631
Angioplasty of a left anterior descending artery originating from the right sinus of Valsalva (discussion in decision making)
632
Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function
633
Angioplasty of complex lesions in ischemic rest angina: Results of the Thrombolysis and Angioplasty in Unstable Angin (TAUSA) Trial
634
Angioplasty of the internal thoracic artery bypass-graft an alternative to reoperation
635
Angioplasty or Surgery for Multivessel Coronary Artery Disease: Comparison of Eligible Registry and Randomized Patients in the EAST Trial and Influence of Treatment Selection on Outcomes
636
Angioplasty through a stent side door
637
Angioplasty versus bypass surgery
638
Angioplasty versus bypass surgery
639
Angioplasty versus bypass surgery
640
Angioplasty versus intravenous thrombolysis for acute myocardial infarction
641
Angioplasty vs medical therapy in the treatment of unilateral atherosclerotic renal artery stenosis: A prospective randomized open blinded-endpoint trial
642
Angioplasty, inflammation, and antiplatelet agents
643
Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: suppression by the isoflavone trans-tetrahydrodaidzein
644
Angiopoietin 2 Level in Type 2 Diabetic Patients with Cardiovascular Complications
645
Angiopoietin like protein 3 (Angptl3), fatty acid binding protein 4 (FABP4) and homeostasis model assessment of insulin resistance (HOMA-IR) among Indonesian obese non diabetic males
646
ANGIOPOIETIN-1 AND -2 MEDIATE PROINFLAMMATORY RESPONSES IN HUMAN ENDOTHELIAL CELLS
647
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis
648
Angiopoietin-1 supports induction of hematopoietic activity in human CD34− bone marrow cells
649
Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation
650
ANGIOPOIETIN-2 IS AN AUTOCRINE REGULATOR OF ENDOTHELIAL CELL RESPONSIVENESS AND VASCULAR HOMEOSTASIS
651
Angiopoietin-like 4 Protein Elevates the Prosurvival Intracellular O2−:H2O2 Ratio and Confers Anoikis Resistance to Tumors
652
Angiopoietin-like protein 2 in psoriasis: a new linkage with metabolic syndrome
653
Angiopoietin-like protein 8 (betatrophin) may inhibit hepatocellular carcinoma through suppressing of the Wnt signaling pathway
654
Angiopoietin-like proteins: Another player in the metabolic field
655
Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy
656
Angiopoietin-like-4 is a potential angiogenic mediator in arthritis
657
Angiopoietins in angiogenesis
658
Angiopoietins in malignancy
659
Angiopoietins: a link between angiogenesis and inflammation
660
Angiosarcoma after conservative treatment and radiation therapy for adenocarcinoma of the breast
661
Angiosarcoma as a sequela of breast cancer treatment with lumpectomy and radiotherapy
662
Angiosarcoma at Dialysis Fistula Site in a Patient on Continuous Ambulatory Peritoneal Dialysis
663
Angiosarcoma in the right atria demonstrated by fusion images of multislice computed tomography and positron emission tomography using F-18 Fluoro-Deoxyglucose
664
Angiosarcoma of Kidney A Case Report and Review of Literature
665
Angiosarcoma of the breast after quadrantectomy and postoperative radiotherapy for carcinoma
666
Angiosarcoma of the breast: a 30 year perspective with an optimistic outlook
667
Angiosarcoma of the chest wall
668
Angiosarcoma of the Liver Presenting with Esophageal Bleeding and Arterio-portal Shunts
669
Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy
670
Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena
671
Angiosarcoma of the Right Atrium with Extension to SVC and IVC Presenting with Complete Heart Block and Significant Pericardial Effusion
672
Angiosarcoma of the right atrium: A diagnostic dilemma
673
Angiosarcoma of the small intestine
674
Angiosarcoma: complication of breast conservation treatment
675
Angiosarcome mammaire primitif : à propos de deux cas
676
Angioscopic and Virtual Histology Intravascular Ultrasound Characteristics of Culprit Lesion Morphology Underlying Coronary Artery Thrombosis
677
Angioscopic Assessment of Coronary Lesions Underlying Thrombus
678
Angioscopic characteristics of coronary narrowing in patients with recurrent myocardial ischemia after myocardial infarction
679
Angioscopic Comparison of Neointimal Coverage Between Zotarolimus- and Sirolimus-Eluting Stents
680
Angioscopic Coronary Macromorphology After Thrombolysis in Acute Myocardial Infarction
681
Angioscopic detection of residual pulmonary thrombi in the differential diagnosis of pulmonary embolism
682
Angioscopic evaluation of angiographically complex coronary lesions,
683
Angioscopic evaluation of atherosclerotic plaques: Validation by histomorphologic analysis and association with stable and unstable coronary syndromes
684
Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent
685
Angioscopic Evaluation of Rotational Atherectomy Followed by Additional Balloon Angioplasty Versus Balloon Angioplasty Alone in Coronary Artery Disease: Prospective, Randomized Study
686
Angioscopic findings during coronary angioplasty of coronary occlusions
687
Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation
688
Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions Original Research Article
689
Angioscopic identification of coronary thrombus in patients with postinfarction angina
690
Angioscopic versus angiographic detection of thrombus during coronary interventional procedures
691
Angioscopy of Culprit Coronary Lesions in Unstable Angina Pectoris and Correlation of Clinical Presentation With Plaque Morphology
692
Angioscopy variables predictive of early angiographic outcome after excimer laser-assisted coronary angioplasty
693
Angioseal use after antegrade femoral arteriotomy in patients undergoing percutaneous revascularization for critical limb ischemia: A case series
694
Angiosome-targeted isolated tibial angioplasty for healing of ischemic foot ulcer: a retrospective study
695
Angiosperm DNA contamination by endophytic fungi: Detection and methods of avoidance
696
Angiosperms (seagrass) within the EU water framework directive: A UK perspective
697
Angiostrongylus eosinophilic meningitis in Egypt
698
Angiostrongylus vasorum from South America and Europe represent distinct lineages
699
Angiotenin II and vacular endothelial growth factor in the vitreou fluid of patient with diabetic macular edema and other retinal diorder
700
Angiotensin (1–7) and Apelin co-therapy: New strategy for heart failure treatment of rats
701
Angiotensin (1-7) Inhibits Ang II-mediated ERK1/2 Activation by Stimulating MKP-1 Activation in Vascular Smooth Muscle Cells
702
Angiotensin 1-7 Administration Increases Renal Blood Flow in the Absence of Bradykinin B2 Receptor in Ovariectomized Estradiol Treated Rats: The Role of Mas Receptor
703
Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference
704
Angiotensin 2 type 1 receptor blocker attenuates atrial structural remodeling in spontaneously hypertensive rats: Role of the suppression of atrial oxidative stress
705
Angiotensin and asymmetric fetal growth
706
Angiotensin and vascular fibrinolytic balance
707
Angiotensin antagonists and renal ischemia/reperfusion: Possible modulation by L-carnitine
708
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade
709
Angiotensin blockade for hypertension: a promise fulfilled
710
Angiotensin Blockade Inhibits Increased JNKs, AP-1 and NF- κ B DNA-binding Activities in Myocardial Infarcted Rats
711
Angiotensin Blockade Inhibits SIF DNA Binding Activities via STAT3 after Myocardial Infarction
712
Angiotensin converting enzyme (ACE D/I) polymorphism and its relation to liver fibrosis progression in Egyptian patients with chronic hepatitis C virus infection
713
Angiotensin Converting Enzyme (ACE) Activity Levels in Insulin-independent Diabetes Mellitus and Effect of ACE levels on Diabetic Patients with Nephropathy
714
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease
715
Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats
716
Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum
717
Angiotensin Converting Enzyme and Myofibroblasts during Tissue Repair in the Rat Heart
718
Angiotensin converting enzyme gene — a candidate gene for addiction to smoking?
719
Angiotensin Converting Enzyme Gene I/D Polymorphism in Pakistani Rheumatic Heart Disease Patients and Healthy Controls
720
Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure
721
Angiotensin Converting Enzyme Gene Insertion/Deletion Variant and Familial Mediterranean Fever-related Amyloidosis
722
Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension
723
Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease
724
Angiotensin Converting Enzyme Gene Polymorphism in Aizheimers Disease
725
Angiotensin Converting Enzyme Gene Polymorphism in Essential Hypertension Based on Ambulatory Blood Pressure Monitoring
726
Angiotensin Converting Enzyme Gene Polymorphism in Iranian Patients with Type 2 Diabetes
727
Angiotensin Converting Enzyme Gene Polymorphism Is Not Related to Essential Hypertension in a Greek Population
728
Angiotensin Converting Enzyme I/D Polymorphism and Chronic Hepatitis C Virus Infection
729
Angiotensin Converting Enzyme I/D Polymorphism in Egyptian Patients with Type 2 Diabetes Mellitus
730
Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension
731
Angiotensin converting enzyme inhibition by captopril influences cardiac work in healthy hearts
732
Angiotensin Converting Enzyme Inhibition Corrects Na+/H+ Exchanger Overactivity in Essential Hypertension
733
Angiotensin converting enzyme inhibition, with quinapril, improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND study (trial on reversing endothelial dysfunction)
734
Angiotensin converting enzyme inhibitor as an additive treatment after successful balloon dilation of a critical pulmonary valve stenosis
735
Angiotensin converting enzyme inhibitor captopril does not improve exercise tolerance or reduce exercise induced myocardial ischemi in patients with angin pectoris
736
Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese
737
Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death
738
ANGIOTENSIN CONVERTING ENZYME- INHIBITORS ASSOCIATED COUGH: A PROSPECTIVE EVALUATION IN HYPERTENSIVES
739
Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection
740
Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism: An Observational Study among Diabetic Hypertensive Subjects in Malaysia
741
Angiotensin- Converting Enzyme Insertion/Deletion Polymorphism and Its Association with Coronary Artery Disease in an Iranian Population
742
Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimerʹs disease and longevity
743
Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan: Ethnic difference of ACE genotype
744
Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis
745
Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris
746
Angiotensin I Converting Enzyme Gene Polymorphism in Chinese Patients With Hypertension
747
Angiotensin I Converting Enzyme Inhibitory Activities of Hydroalcoholic Extracts of Nardostachys jatamansi, Prangos ferulacea and Marrubium vulgare
748
Angiotensin I Modulates Ca-transport Systems in the Rat Heart Through Angiotensin II
749
Angiotensin I retention behavior on Butyl-Sepharose under linear loading chromatographic conditions
750
Angiotensin I-Converting Enzyme (ACE) Gene Polymorphism in Relation to Physical Performance, Cognition and Survival—A Follow-up Study of Elderly Danish Twins
751
Angiotensin I–converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene
752
Angiotensin I-converting enzyme (ACE) inhibitory activities of sardinelle (Sardinella aurita) by-products protein hydrolysates obtained by treatment with microbial and visceral fish serine proteases
753
Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion
754
Angiotensin I–converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort
755
Angiotensin I–converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women
756
Angiotensin I-Converting Enzyme Gene Polymorphism and Acute Response to Captopril in Essential Hypertension
757
Angiotensin I-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease Original Research Article
758
Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor
759
Angiotensin I-converting enzyme inhibitory compounds in white and red wines
760
Angiotensin I-converting enzyme inhibitory oligo-tyrosine peptides synthesized by α-chymotrypsin
761
Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats
762
Angiotensin I-converting enzyme inhibitory peptides in douchi, a Chinese traditional fermented soybean product
763
Angiotensin I-converting enzyme inhibitory properties of lentil protein hydrolysates: Determination of the kinetics of inhibition
764
Angiotensin I–converting enzyme insertion/insertion genotype as a genetic risk factor for cardiovascular disease
765
Angiotensin I-converting enzyme-inhibitory peptide fractions from albumin 1 and globulin as obtained of amaranth grain
766
Angiotensin II (Ang II) stimulates sympathetic nerve (SNS) activity through activation of oxidative stress
767
Angiotensin II (AngII) activates nuclear factor-κB via AT1 and AT2 receptors in the kidney
768
Angiotensin II activates intermediate-conductance Ca2+-activated K+ channels in arterial smooth muscle cells
769
Angiotensin II Activates Stat5 Through Jak2 Kinase in Cardiac Myocytes
770
Angiotensin II activation of Src mediates ERK stimulation in human vascular smooth muscle cells
771
Angiotensin II and atherosclerosis
772
Angiotensin II and cardiomyocyte apoptosis in the SHR
773
Angiotensin II and Intracellular Calcium of Adult Cardiac Fibroblasts
774
Angiotensin II and the pathophysiology of cardiovascular remodeling
775
Angiotensin II and trials of cardiovascular outcomes
776
Angiotensin II antagonists block ethanol effects on the aerial righting reflex
777
Angiotensin II antagonists demonstrate greater long-term persistence versus other antihypertensive medications
778
Angiotensin II antagonists for hypertension: are there differences in efficacy?
779
Angiotensin II antagonists for hypertension: there are differences in efficacy
780
Angiotensin II antagonists for hypertension: there are differences in efficacy: The reply
781
Angiotensin II AT1 Receptor Blockade Improves Renal Perfusion in Hypercholesterolemia
782
Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys
783
Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension
784
Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis
785
Angiotensin II Differentially Induces Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Production and Disturbs MMP/TIMP Balance
786
Angiotensin II directly inhibits protein synthesis in murine myotubes
787
Angiotensin II Elevates Nitric Oxide Synthase 3 Expression and Nitric Oxide Production Via a Mitogen-Activated Protein Kinase Cascade in Ovine Fetoplacental Artery Endothelial Cells
788
Angiotensin II enhances cardiac Na+/Ca2+ exchanger current via an autocrine release of endothelin
789
Angiotensin II Enhances the Expression of Giα in A10 Cells (Smooth Muscle): Relationship with Adenylyl Cyclase Activity
790
Angiotensin II increases expression and secretion of cathepsin F in cultured human monocyte-derived macrophages: An angiotensin II type 2 receptor-mediated effect
791
Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: A mechanism by which angiotensin II antagonizes cGMP signaling
792
Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway
793
Angiotensin II increases the release of endothelin-I from human cultured endothelial cells but does not regulate its circulating levels
794
Angiotensin II induced hyperplasia and hypertrophy in human vascular smooth muscle cells are mediated via AT1 receptors
795
Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro
796
Angiotensin II induces DNA injury in human umbilical artery smooth muscle cells via a mechanism which involves hydrogen peroxide
797
Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice
798
Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor
799
Angiotensin II induces mitochondrial dysfunction and promotes apoptosis via JNK signalling pathway in primary mouse calvaria osteoblast
800
Angiotensin II Induces Nuclear Factor- κ B Activation in Cultured Neonatal Rat Cardiomyocytes Through Protein Kinase C Signaling Pathway
801
Angiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cells
802
Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice
803
Angiotensin II inhibition and prevention of atrial fibrillation and stroke
804
Angiotensin II inhibition during myocardial ischemia–reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction
805
Angiotensin II inhibition of Ca2+ currents is independent of ATR1 angiotensin II receptor activation in rat adult vagal afferent neurons
806
Angiotensin II Inhibits Insulin-Induced egr-1 Expression in Mesangial Cells
807
Angiotensin II inhibits the forearm vascular response to increased arterial pressure in humans
808
Angiotensin II Mechanisms in Ischemic Heart Disease: Pathophysiology and Survival
809
Angiotensin II mechanisms in the renal responses to hypertension and diabetes mellitus.
810
Angiotensin II Modulates ANP-R2/ANP-C Receptor-mediated Inhibition of Adenylyl Cyclase in Vascular Smooth Muscle Cells: Role of Protein Kinase C
811
Angiotensin II Plays a Critical Role in Alcohol-Induced Cardiac Nitrative Damage, Cell Death, Remodeling, and Cardiomyopathy in a Protein Kinase C/Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Dependent Manner
812
Angiotensin II Plays an Important Role in Maintaining Blood Pressure in Postmenopausal Women Receiving Hormone Replacement Therapy
813
Angiotensin II Potentiates DNA Synthesis in AT-1 Transformed Cardiomyocytes
814
Angiotensin II promotes ICAM-1 expression in vitro and soluble ICAM-1 secretion in vivo
815
Angiotensin II receptor antagonism does not prevent tolerance to continuous transdermal nitroglycerin
816
Angiotensin II Receptor Antagonist Blocks the Expression of Connexin43 Induced by Cyclical Mechanical Stretch in Cultured Neonatal Rat Cardiac Myocytes
817
Angiotensin II receptor antagonists Review Article
818
Angiotensin II receptor blockade and end-organ protection
819
Angiotensin II receptor blockade by losartan reduces the incidence of heart failure after an MI in rat
820
Angiotensin II receptor blockade does not improve left ventricular function andremodeling in subacute mitral regurgitation in the dog
821
Angiotensin II receptor blockade in diabetic nephropathy
822
Angiotensin II receptor blockade in diabetic nephropathy
823
Angiotensin II receptor blockade reduces expression of basic fibroblast growth factor mRNA in the balloon injured rat carotid artery. Quantification by competitive polymerase chain reaction
824
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study Original Research Article
825
ANGIOTENSIN II RECEPTOR BLOCKER VALSARTAN ENHANCES GLUCOSE-INDUCED INSULIN SECRETION
826
Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation
827
Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension
828
Angiotensin II Receptor Blockers Downsize Adipocytes in Spontaneously Type 2 Diabetic Rats With Visceral Fat Obesity
829
Angiotensin II receptor blockers: review of the binding characteristics
830
Angiotensin II Receptor Subtypes and Biological Responses in the Rat Heart
831
Angiotensin II Receptor Type 1 mRNA is Upregulated in Atria of Patients with End-stage Heart Failure
832
Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease Original Research Article
833
Angiotensin II reduces alcohol intake and choice in water- or food-restricted rats
834
Angiotensin II regulates AT2 subtype receptor promoter activity and expression in rat primary endothelial cell
835
Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR
836
Angiotensin II Release From Rabbit Intrarenal Arteries: A Critical Assessment
837
Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway
838
Angiotensin II Stimulated Expression of Transforming Growth Factor-β1in Cardiac Fibroblasts and Myofibroblasts
839
Angiotensin II stimulates cardiac chloride/bicarbonate exchange activity by phosphorylation of serine 67 of AE3
840
Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure
841
Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure
842
Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins Original Research Article
843
Angiotensin II stimulates phosphorylation and nuclear accumulation of R-Smad 2 in cultured cardiac fibroblasts: T-type Ca channel blockade in vascular smooth muscle cells causes G1S cell cycle arrest
844
Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties
845
Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non–insulin-dependent diabetes mellitus
846
Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide
847
Angiotensin II type 1 receptor (A1166C) gene polymorphism in Egyptian adult hemodialysis patients
848
Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure
849
Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer
850
Angiotensin II Type 1 Receptor Blockade Abolishes Specific KATPChannel Gene Expression in Rats with Myocardial Ischemia
851
Angiotensin II type 1 receptor blockade improves cardiac expression of hsp72 and tolerance against ischemia/reperfusion injury in insulin resistance rat
852
Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model
853
Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice
854
Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study
855
Angiotensin II Type 1 Receptor Gene A1166C Polymorphism Was Not Associated With Acute Coronary Syndrome in an Iranian Population
856
Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome
857
Angiotensin II Type 1 Receptor Gene Polymorphism Is Associated With Increase of Left Ventricular Mass But Not With Hypertension
858
Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events
859
Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation
860
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists
861
Angiotensin II type-I receptor antagonists in the treatment of heart failure
862
Angiotensin II upregulates transforming growth factor-β type I receptor on rat vascular smooth muscle cells
863
Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension
864
Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart
865
Angiotensin II, VEGF, and diabetic retinopathy
866
Angiotensin II, VEGF, and diabetic retinopathy
867
Angiotensin II, VEGF, and diabetic retinopathy
868
Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A2-mediated release of arachidonic acid
869
Angiotensin II-induced C-reactive protein generation: Inflammatory role of vascular smooth muscle cells in atherosclerosis
870
Angiotensin II-induced ionic currents and signalling pathways in submandibular ganglion neurons
871
Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats
872
Angiotensin II-Mediated apoptosis and P53 expression in human cardiomyocytes
873
Angiotensin II-mediated Growth and Antigrowth Effects in Cultured Neonatal Rat Cardiac Myocytes and Fibroblasts
874
Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma
875
Angiotensin receptor antagonists
876
Angiotensin receptor antagonists: focus on losartan
877
Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome
878
Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling: A possible link between beta-adrenergic receptor kinase-1 and protein kinase C epsilon isoform Original Research Article
879
Angiotensin Receptor Blocker and N-Acetyl Cysteine for Reduction of Proteinuria in Patients With Type 2 Diabetes Mellitus
880
Angiotensin Receptor Blockers – finally the evidence is coming in: IDNT and RENAAL
881
Angiotensin Receptor Blockers and Cardiovascular Protection: Are We ONTARGET?
882
Angiotensin receptor blockers and diuretics as combination therapy: clinical implications
883
Angiotensin Receptor Blockers and Magnesium Status in Essential Hypertension
884
Angiotensin receptor blockers in heart failure: A work in progress
885
Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials
886
Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
887
Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
888
Angiotensin Receptor Blockers: Current Status and Future Prospects
889
Angiotensin receptor blockers: how important is selectivity?
890
Angiotensin receptor blockers—finally the evidence is coming in: IDNT and RENAAL
891
Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series
892
Angiotensin Receptor-1 Blocker Inhibits Atherosclerotic Changes and Endothelial Disruption of the Aortic Valve in Hypercholesterolemic Rabbits Original Research Article
893
Angiotensin Receptors in Cardiac and Renal Hypertrophy in Rats
894
Angiotensin receptors: history and mysteries
895
Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis
896
Angiotensin Type 2 Receptor Gene Polymorphisms and Susceptibility to Preeclampsia
897
Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons
898
Angiotensin-(1–7) and vasopeptidase inhibition
899
Angiotensin-(1–7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala
900
ANGIOTENSIN, BRADYKININ AND CONVERTING ENZYME IN IMPOSED AND PHYSIOLOGICAL FLOW-RELATED ARTERIAL REMODELING.
901
Angiotensin, fibrinolysis, and vascular homeostasis
902
Angiotensin-Converting Enzyme (ACE) Inhibitor Angioedema: The Silent Epidemic
903
Angiotensin-converting enzyme (ACE) inhibitors revert abnormal right ventricular filling in patients with restrictive left ventricular disease
904
Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis
905
Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells
906
angiotensin-converting enzyme 2 (ace2) gene polymorphism in patients with type 2 diabetes (t2dm) in thi-qar, iraq
907
Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy
908
Angiotensin-converting enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries
909
Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease
910
Angiotensin-Converting Enzyme and Heart Chymase gene Polymorphisms in Hypertrophic Cardiomyopathy
911
Angiotensin-converting enzyme and p22phox polymorphisms and the risk of coronary heart disease in a low-risk Spanish population
912
Angiotensin-converting Enzyme and Renin Inhibition Activities, Antioxidant Properties, Phenolic and Flavonoid Contents of Cuphea ignea A. DC.
913
Angiotensin-Converting Enzyme Assay Optimization:Influence of Various Buffers and Their Concentrations
914
Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure
915
Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension
916
Angiotensin-converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: Identifying the guideposts for navigating the genetics landscape
917
Angiotensin-converting enzyme gene polymorphism and common carotid stiffness: The Rotterdam study
918
Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients
919
Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy
920
Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy
921
Angiotensin-Converting Enzyme Gene Polymorphism in Systemic Hypertension
922
Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis
923
Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction
924
Angiotensin-converting enzyme genetic variants do not influence response to risperidone in autistic children
925
Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes
926
Angiotensin-Converting Enzyme Genotype Predicts Cardiac and Autonomic Responses to Prolonged Exercise Original Research Article
927
Angiotensin-Converting Enzyme Genotypes and Risk for Myocardial Infarction in Women
928
Angiotensin-Converting Enzyme I/D Polymorphism in Behçet’s Disease
929
Angiotensin-converting enzyme inhibition after myocardial infarction: the trandolapril cardiac evaluation study
930
Angiotensin-Converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats
931
Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet
932
Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients
933
Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium
934
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation Original Research Article
935
Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function: Ischemia Management with Accupril post–bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the othe
936
Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non–ST-elevation acute coronary syndromes
937
Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling
938
Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction
939
Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane
940
Angiotensin-converting enzyme inhibition to enhance vascular health—clinical and research models
941
Angiotensin-converting enzyme inhibition, autonomic activity, and hemodynamics in patients with heart failure who perform isometric exercise
942
Angiotensin-Converting Enzyme Inhibitor as a Marker, Not a Risk Factor, for Poor Prognosis
943
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction Original Research Article
944
Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure,
945
Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure
946
Angiotensin-converting enzyme inhibitor dosing in heart failure: What is optimal?
947
Angiotensin-converting enzyme inhibitor for epirubicin-induced dilated cardiomyopathy
948
Angiotensin-converting enzyme inhibitor meta-analysis provides misleading conclusion
949
Angiotensin-Converting Enzyme Inhibitor Prevents Plasminogen Activator Inhibitor-1 Expression in a Rat Model with Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis
950
Angiotensin-Converting Enzyme Inhibitor Therapy Affects Left Ventricular Mass in Patients With Ejection Fraction >40% After Acute Myocardial Infarction
951
Angiotensin-Converting Enzyme Inhibitor Therapy at the Time of Coronary Artery Bypass Surgery: When a Friend Turns Mean-Spirited
952
Angiotensin-converting enzyme inhibitor treatment after myocardial infarction: A selective approach for maximum benefit
953
Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarction
954
Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
955
Angiotensin-converting enzyme inhibitors after myocardial infarction: Indications and timing
956
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease
957
Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study
958
Angiotensin-converting enzyme inhibitors and myocardial infarction: A class effect?
959
Angiotensin-Converting Enzyme Inhibitors and Outcome Among Patients With Heart Failure and Renal Insufficiency: Need for a Prospective Study
960
Angiotensin-converting enzyme inhibitors and β-blockers in long-term treatment of dilated cardiomyopathy
961
Angiotensin-converting enzyme inhibitors as a cause of unilateral tongue angioedema in a 68-year-old woman
962
Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy
963
Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation
964
Angiotensin-Converting Enzyme Inhibitors Can Increase the Transvalvular Gradient Among Patients With Aortic Stenosis
965
Angiotensin-converting enzyme inhibitors in adults after the mustard procedure
966
Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease
967
Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Original Research Article
968
Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: A pharmaceutical industry perspective, ,
969
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials Original Research Article
970
Angiotensin-Converting Enzyme Inhibitors Potentiate Preconditioning Through Bradykinin B2 Receptor Activation in Human Heart
971
Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level
972
Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline-mediated endothelium-dependent relaxation in internal thoracic artery of hypertensive patients
973
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists and Calcium Channel Blocking Agents: Review of Potential Benefits and Possible Adverse Reactions
974
Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure
975
Angiotensin-converting enzyme inhibitors: a new therapy for atrial fibrillation?
976
Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefit
977
Angiotensin-converting enzyme inhibitors: optimal management of cardiovascular risk
978
Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in General Population of West Azarbaijan, Iran
979
Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris
980
Angiotensin-converting enzyme insertion/deletion polymorphism in angina pectoris with normal coronary arteriograms
981
Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults
982
Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults: Reply
983
Angiotensin-Converting Enzyme-2 Overexpression Improves Left Ventricular Remodeling and Function in a Rat Model of Diabetic Cardiomyopathy
984
Angiotensin-converting enzymeinhibitors and angiotensin iireceptor blockers synergistically increasecoronary blood flow in canine ischemic myocardium: Role of bradykinin
985
Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training
986
Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial
987
Angiotensin-converting-enzyme inhibitors in early pregnancy
988
Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials
989
Angiotensin-I converting enzyme inhibitory peptides from antihypertensive skate (Okamejei kenojei) skin gelatin hydrolysate in spontaneously hypertensive rats
990
Angiotensin-I-converting enzyme (ACE)-inhibitory and antihypertensive properties of squid skin gelatin hydrolysates
991
Angiotensin-I-converting enzyme and prolyl endopeptidase inhibitory peptides from natural sources with a focus on marine processing by-products
992
Angiotensin-I-converting enzyme inhibitory activity and bitterness of enzymatically-produced hydrolysates of shrimp (Pandalopsis dispar) processing byproducts investigated by Taguchi design
993
Angiotensin-II activates apoptosis, proliferation and protein synthesis in the left heart ventricle of newborn albino rats
994
Angiotensin-II receptor antagonist losartan improves the exercise tolerance in patients with symptomatic congestive heart failure
995
Angiotensin-II type 1 receptor polymorphism is associated with an increased vasoreactivity to angiotensin II in human arteries
996
Angiotensin-II-receptor inhibitors in pregnancy
997
Angiotensin-II-receptor inhibitors in pregnancy
998
Angiotensin-II-receptor inhibitors in pregnancy
999
Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: The atherosclerosis risk in communities and the NHLBI family heart studies Original Research Article
1000
Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia
